- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01230554
Product Performance of a Daily Disposable Contact Lens
August 13, 2019 updated by: Bausch & Lomb Incorporated
A Study to Assess the Product Performance of a Daily Disposable Contact Lens
The objective of this one week, single group, bilateral, open-label study is to evaluate the product performance of the Bausch & Lomb daily disposable cosmetic tint contact lens (Test) when worn on a daily disposable basis by adapted current wearers of a marketed opaque tinted soft contact lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
212
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 556741
- Bausch & Lomb
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 38 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Subjects must be females of Chinese descent and of legal age and no older than 38. OR subjects that are females of Chinese descent and are at least 15 years of age and less than the legal age must: have a parent/legal guardian provide informed consent.
- Subjects must have clear central corneas and be free of any anterior segment disorders.
- Subjects must be adapted current wearers of marketed opaque tinted soft contact lenses, wear their lenses two days or more per week, and wear a lens in each eye.
Exclusion Criteria:
- Subjects who have worn gas permeable (GP) contact lenses within the last 30 days or have worn polymethylmethacrylate (PMMA) lenses within the last three months.
- Subjects who have any systemic disease affecting ocular health.
- Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
- Subjects with an active ocular disease or are using any ocular medication.
- Subjects with any scar or neovascularization within the central 4 mm of the cornea.
- Subjects who are aphakic or amblyopic.
- Subjects who have had any corneal surgery (eg, refractive surgery).
- Subjects who currently wear monovision, multifocal, or toric contact lenses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prism I
Bausch & Lomb daily disposable cosmetic tint contact lens
|
Bausch & Lomb daily disposable cosmetic tint contact lens worn on a daily disposable basis for 1 week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Market Research Survey
Time Frame: 1 week
|
Online subjective assessments that subjects responded to after wearing the study lenses for at least one week.
Subjects were asked to rate their overall opinion as: Excellent, Very Good, Good, Fair, or Poor.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Evaluation - Centration
Time Frame: Over all study visits through 1 week
|
To determine proper lens parameters the lens relationship to the eye was observed using a slit lamp.
Lens centration, meaning the lens should provide full corneal coverage, was assessed during the slit lamp evaluation.
Findings were reported as: Excellent, Good, Fair, or Poor.
|
Over all study visits through 1 week
|
|
Lens Evaluation - Movement
Time Frame: Over all study visits through 1 week
|
To determine proper lens parameters the lens relationship to the eye was observed using a slit lamp. Lens movement, meaning the lens should provide discernible movement with:
|
Over all study visits through 1 week
|
|
Visual Acuity - Distance High Contrast logMAR (Logarithm of the Minimum Angle of Resolution) Lens Visual Acuity (VA).
Time Frame: Over all study visits for 1 week
|
For determination of high contrast VA, the subject was to be seated so that the distance from the subject's eyes to the logMAR chart is 6.5 feet (2.0 meters).
The chart should be at eye level for the subject.
The logMAR charts have two alternative letter sequences from 28 letters (0.3 logMAR) to 62 letters (-0.3 logMAR).
The visual acuity should be measured through the phoropter using the distance refractive correction with the addition of +0.50D to compensate for the reduced test distance of 6.5 feet (2.0 meters).
|
Over all study visits for 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
November 1, 2010
Study Registration Dates
First Submitted
October 27, 2010
First Submitted That Met QC Criteria
October 28, 2010
First Posted (Estimate)
October 29, 2010
Study Record Updates
Last Update Posted (Actual)
August 28, 2019
Last Update Submitted That Met QC Criteria
August 13, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 654
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on Daily disposable cosmetic tint lens
-
CooperVision, Inc.CompletedMyopiaUnited States
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
CooperVision, Inc.Completed
-
National University of MalaysiaCompletedColor Vision Defects | Color BlindnessMalaysia
-
CooperVision, Inc.Completed
-
University of ValenciaWrocław University of Science and TechnologyCompletedTear Film Hyperosmolarity
-
CooperVision, Inc.Completed
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
CooperVision, Inc.Completed